Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

DSM-Firmenich (DSFIR.AS)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (€) Price Target (€) Rating
2021-08-13177.65175.00Buy
2021-08-24181.70200.00Buy
2022-01-18176.70205.00Buy
2022-02-16164.75190.00Buy
2022-03-30162.80185.00Buy
2022-05-04153.30180.00Buy
2022-07-14141.55166.00Buy
2022-08-03146.05170.00Buy
2022-10-03118.60155.00Buy
2022-11-02113.75145.00Buy
2022-12-13124.80143.00Buy
2023-01-06121.00140.00Buy
2023-03-24109.20137.00Buy
2023-05-03116.00136.00Buy
2023-07-19103.30118.00Buy
2023-08-1584.26108.00Buy
2023-10-0278.26101.00Buy
2023-12-2092.42102.00Buy
2024-02-16103.02122.00Buy
2024-04-03104.90126.00Buy
2024-05-09104.95122.00Buy
2024-06-27106.60129.00Buy
2024-07-31118.05133.00Buy
2024-09-30123.65137.00Buy
2024-11-01108.55133.00Buy

Disclosures

  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • An employee of UBS is an officer, director, or advisory board member of this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.